{"id":"https://openalex.org/W4379984452","doi":"https://doi.org/10.1158/1538-7445.am2023-3864","title":"Abstract 3864: Targeting IL-6/STAT3 signaling in EGFR-mutant drug tolerant persister cells","display_name":"Abstract 3864: Targeting IL-6/STAT3 signaling in EGFR-mutant drug tolerant persister cells","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4379984452","doi":"https://doi.org/10.1158/1538-7445.am2023-3864"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-3864","doi":"https://doi.org/10.1158/1538-7445.am2023-3864","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-3864","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054420898","display_name":"Sonia A. Patel","orcid":"https://orcid.org/0000-0002-6494-7872","observed_orcids":["https://orcid.org/0000-0002-6494-7872"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonia A. Patel","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040693824","display_name":"Monique B. Nilsson","orcid":"https://orcid.org/0000-0002-0975-8833","observed_orcids":["https://orcid.org/0000-0002-0975-8833"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monique Nilsson","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081920875","display_name":"Yan Yang","orcid":"https://orcid.org/0000-0003-0131-7993","observed_orcids":["https://orcid.org/0000-0003-0131-7993"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Yang","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100683846","display_name":"Li Shen","orcid":"https://orcid.org/0000-0001-8427-9448","observed_orcids":["https://orcid.org/0000-0001-8427-9448"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Shen","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062224682","display_name":"Alissa Poteete","orcid":"https://orcid.org/0000-0002-6091-2840","observed_orcids":["https://orcid.org/0000-0002-6091-2840"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alissa Poteete","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058694333","display_name":"Xiaoxing Yu","orcid":"https://orcid.org/0000-0002-1607-0973","observed_orcids":["https://orcid.org/0000-0002-1607-0973"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoxing Yu","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000349318","display_name":"Xiaoyang Ren","orcid":"https://orcid.org/0000-0002-2177-2937","observed_orcids":["https://orcid.org/0000-0002-2177-2937","https://orcid.org/0009-0009-5167-4981"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoyang Ren","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007462622","display_name":"Xiuning Le","orcid":"https://orcid.org/0000-0002-8554-1185","observed_orcids":["https://orcid.org/0000-0002-8554-1185","https://orcid.org/0009-0003-5164-3567"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiuning Le","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048380048","display_name":"John Victor Heymach","orcid":"https://orcid.org/0000-0001-9068-8942","observed_orcids":["https://orcid.org/0000-0001-9068-8942"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Heymach","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"3864","last_page":"3864"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.8920000195503235},{"id":"https://openalex.org/keywords/drug-tolerant-persister-cells","display_name":"drug-tolerant persister cells","score":0.9160000085830688},{"id":"https://openalex.org/keywords/il-6-signaling","display_name":"IL-6 signaling","score":0.6830000281333923},{"id":"https://openalex.org/keywords/stat3-phosphorylation","display_name":"STAT3 phosphorylation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/osimertinib-resistance","display_name":"osimertinib resistance","score":0.9190000295639038},{"id":"https://openalex.org/keywords/egfr-tki-resistance","display_name":"EGFR tyrosine kinase inhibitor resistance","score":0.9079999923706055},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9070000052452087},{"id":"https://openalex.org/keywords/soluble-il-6-receptor","display_name":"soluble IL-6 receptor","score":0.7770000100135803},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.5479999780654907},{"id":"https://openalex.org/keywords/nk-cell-inhibition","display_name":"NK cell inhibition","score":0.9670000076293945},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.4560000002384186},{"id":"https://openalex.org/keywords/egfr-l858r-mutation","display_name":"L858R mutation","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.728462815284729},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6379346251487732},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6282550692558289},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4750485420227051},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.44525250792503357},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4187955856323242},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3797134757041931},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3520790934562683},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2934519648551941},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.2896932363510132},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.207794189453125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20138433575630188},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-3864","doi":"https://doi.org/10.1158/1538-7445.am2023-3864","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-3864","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2964016456","https://openalex.org/W4410922540","https://openalex.org/W4393073440","https://openalex.org/W4409100134","https://openalex.org/W2484344549","https://openalex.org/W4403419652","https://openalex.org/W4313454050","https://openalex.org/W2215679079","https://openalex.org/W7130646255","https://openalex.org/W2900086215"],"abstract_inverted_index":{"Abstract":[0],"While":[1,255],"the":[2,50,151,174,182,194,199,221,241,256,316,362,410,416,435,480],"majority":[3],"of":[4,39,52,56,76,124,142,176,186,196,202,260,279,315,344,355,381,403,412,418,430,439,479],"epidermal":[5],"growth":[6,90,108],"factor":[7],"receptor":[8],"(EGFR)":[9],"mutant":[10,178,214,346],"non-small":[11],"cell":[12,184,257],"lung":[13,347],"cancer":[14],"(NSCLC)":[15],"patients":[16],"initially":[17,48],"respond":[18],"to":[19,34,45,82,101,105,136,150,167,252,272],"treatment":[20],"with":[21,42,133,220,333,371,390],"an":[22,134,406],"EGFR":[23,118,126,152,177,203,213,222,422],"tyrosine":[24],"kinase":[25],"inhibitor":[26],"(TKI),":[27],"most":[28],"will":[29],"eventually":[30,79],"develop":[31],"acquired":[32,43],"resistance":[33,44,120,149],"these":[35],"agents.":[36],"The":[37,94],"evolution":[38,411],"tumor":[40,57,86,143],"cells":[41,58,69,87,100,144,164,188,210,219,249,269,284,301,325,329,331],"targeted":[46],"agents":[47],"involves":[49],"persistence":[51],"a":[53,61,312,352],"drug-tolerant":[54,208],"subpopulation":[55],"which":[59],"display":[60],"transient":[62],"and":[63,91,113,189,216,228,243,295,308,358,364,492],"flexible":[64],"resistant":[65,85,163],"state.":[66],"These":[67],"persister":[68,99,209,248,268,283,300,324,440,474],"can":[70],"remain":[71,102],"quiescent":[72],"for":[73,225,335,373,392,483],"prolonged":[74],"periods":[75],"time,":[77],"but":[78],"give":[80],"rise":[81],"fully":[83],"drug":[84,298,413,472],"that":[88,97,117,121,145,156,172,235,310,401],"resume":[89],"metastatic":[92],"spread.":[93],"signaling":[95,318,432,469],"pathways":[96],"allow":[98],"viable":[103],"or":[104,128,330,375,394,437],"re-activate":[106],"expansive":[107],"are":[109,384,442],"poorly":[110],"understood.":[111],"We":[112,170,233,288],"others":[114],"have":[115],"reported":[116],"TKI":[119,153,204,223,423],"occurs":[122],"independent":[123],"secondary":[125],"mutations":[127],"MET":[129],"amplification":[130],"is":[131,405],"associated":[132],"epithelial":[135],"mesenchymal":[137],"transition":[138],"(EMT).":[139],"Our":[140],"analysis":[141],"had":[146],"undergone":[147],"EMT-mediated":[148],"osimertinib":[154,224,334,372,391],"revealed":[155],"interleukin-6":[157],"(IL-6)":[158],"was":[159,237,262,320],"highly":[160],"upregulated":[161,238],"in":[162,173,198,246,266,282,292,297,323,367,386,409,420,470],"as":[165,250,270,326],"compared":[166,251,271,327],"parental":[168,253,273,328],"cells.":[169,191,254,475],"find":[171],"setting":[175],"NSCLC,":[179],"IL-6":[180,197,231,236,317,357,382,404,419,431],"suppresses":[181],"anti-tumor":[183],"activity":[185],"T":[187],"NK":[190],"To":[192],"assess":[193],"role":[195,417],"early":[200,407],"events":[201],"resistance,":[205,424],"we":[206,275,349],"generated":[207],"by":[211,285,302],"treating":[212],"HCC4006":[215],"HCC827":[217],"NSCLC":[218],"10":[226],"days":[227],"then":[229],"assessed":[230,290],"expression.":[232],"observed":[234,276,309,351],"at":[239,361],"both":[240,356],"RNA":[242,363],"protein":[244,293,305,365],"levels":[245,366,380],"EGFR-TKI":[247,267],"surface":[258],"expression":[259,294,360],"IL6R":[261,281],"not":[263],"significantly":[264,321],"increased":[265,277],"cells,":[274],"secretion":[278],"soluble":[280],"ELISA":[286],"assay.":[287],"next":[289],"changes":[291],"activation":[296],"tolerant":[299,473],"reverse":[303],"phase":[304],"array":[306],"(RPPA)":[307],"p-STAT3,":[311],"key":[313],"component":[314],"pathway,":[319],"elevated":[322,385],"treated":[332,370,389],"24":[336],"hours.":[337],"Using":[338],"genetically":[339],"engineered":[340],"mouse":[341],"models":[342],"(GEMM)":[343],"EGFRL858R":[345,387],"cancer,":[348],"also":[350,383],"similar":[353],"upregulation":[354,402],"p-STAT3":[359],"EGFR-mutant":[368,471],"tumors":[369],"2":[374,393],"4":[376,395],"weeks.":[377,396],"Additionally,":[378],"circulating":[379],"GEMMs":[388],"Collectively,":[397],"our":[398],"data":[399],"indicates":[400],"event":[408],"resistance.":[414],"Given":[415],"promoting":[421],"further":[425],"studies":[426],"investigating":[427],"whether":[428],"targeting":[429],"may":[433],"impair":[434],"survival":[436],"outgrowth":[438],"populations":[441],"warranted.":[443],"Citation":[444],"Format:":[445],"Sonia":[446],"A.":[447],"Patel,":[448],"Monique":[449],"Nilsson,":[450],"Yan":[451],"Yang,":[452],"Li":[453],"Shen,":[454],"Jing":[455],"Wang,":[456],"Alissa":[457],"Poteete,":[458],"Xiaoxing":[459],"Yu,":[460],"Xiaoyang":[461],"Ren,":[462],"Xiuning":[463],"Le,":[464],"John":[465],"Heymach.":[466],"Targeting":[467],"IL-6/STAT3":[468],"[abstract].":[476],"In:":[477],"Proceedings":[478],"American":[481],"Association":[482],"Cancer":[484,503],"Research":[485],"Annual":[486],"Meeting":[487],"2023;":[488],"Part":[489],"1":[490],"(Regular":[491],"Invited":[493],"Abstracts);":[494],"2023":[495],"Apr":[496],"14-19;":[497],"Orlando,":[498],"FL.":[499],"Philadelphia":[500],"(PA):":[501],"AACR;":[502],"Res":[504],"2023;83(7_Suppl):Abstract":[505],"nr":[506],"3864.":[507]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-06-10T00:00:00"}